LeMaitre to Participate at Upcoming Investor Conferences in March
BURLINGTON, Mass., March 03, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in three upcoming investor conferences in March.
37th Annual ROTH Conference
Monday, March 17, 2025
The Laguna Cliffs Marriott, Dana Point, CA
Management will present at 4:00 PM PDT
KeyBanc Healthcare Forum
Wednesday, March 19, 2025
Virtual Event
Management will present at 1:30 PM EDT
Oppenheimer 35th Annual Healthcare MedTech & Services Conference
Thursday, March 20, 2025
Virtual Event
Management will present at 10:00 AM EDT
About LeMaitre
LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.
LeMaitre is a registered trademark of LeMaitre Vascular, Inc.
Contact: Greg Manker Director Business Development & Investor Relations LeMaitre Vascular, Inc. Phone: (781) 362-1260 Email: gmanker@lemaitre.com
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
